539519 — Tavexia Lifecare Cashflow Statement
0.000.00%
- IN₹441.19m
- IN₹465.30m
- IN₹322.49m
Annual cashflow statement for Tavexia Lifecare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | C2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.25 | 6.6 | 15.3 | 31.9 | 1.66 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.217 | 1.8 | 0.137 | -6.37 | -0.168 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -10.3 | -26 | -46.4 | -27.3 | -149 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -9.22 | -15.1 | -27.7 | 1.09 | -143 |
| Capital Expenditures | -2.17 | -15.8 | -0.021 | -4.82 | -31.9 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 9.46 | -81 | -27.6 | — | -4.17 |
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 7.29 | -96.8 | -27.7 | -4.82 | -36.1 |
| Financing Cash Flow Items | -0.217 | 71.7 | -0.136 | -0.462 | 2.75 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.283 | 112 | 55.1 | 3.71 | 193 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.65 | 0.1 | -0.305 | -0.019 | 13.7 |